Pharmacodynamics of regulatory T cells in mice and humans treated with low-dose IL-2

Affiliations

• ¹ AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation- Immunopathology-Biotherapy Department (i2B), Paris, France; Sorbonne Université, UPMC Univ Paris 06, Immunology-Immunopathology-Immunotherapy (I3), Paris, France.
• ² Service de Pharmacologie, Toxicologie et centre de pharmacovigilance, CHU et faculté de santé, Université d'Angers, Angers, France.
• ³ Sorbonne Université, UPMC Univ Paris 06, Immunology-Immunopathology-Immunotherapy (I3), Paris, France.
• ⁴ AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation- Immunopathology-Biotherapy Department (i2B), Paris, France; Sorbonne Université, UPMC Univ Paris 06, Immunology-Immunopathology-Immunotherapy (I3), Paris, France. Electronic address: [email protected].